• S2 Ep4: Myelodysplastic Syndromes & Acute Myeloid Leukemia

  • Jun 3 2022
  • Length: 23 mins
  • Podcast

S2 Ep4: Myelodysplastic Syndromes & Acute Myeloid Leukemia  By  cover art

S2 Ep4: Myelodysplastic Syndromes & Acute Myeloid Leukemia

  • Summary

  • Mikkael Sekeres, MD, is no stranger to rare disease. In his own words, there are rare diseases and then there are very rare diseases. Sickle cell is a rare condition with an incidence rate of just over 100 per 100,000 people. Sekeres focuses much of his treatment on patients with bone marrow disorders like myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML). These conditions have an incidence rate of approximately 5 per 100,000. In this episode he shares insight on treatment practices, clinical trial procedures and hurdles, as well as the importance of finding reliable sources for information. 
    Show more Show less
activate_primeday_promo_in_buybox_DT

What listeners say about S2 Ep4: Myelodysplastic Syndromes & Acute Myeloid Leukemia

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.